SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Vaxart, (VXRT) — Apr 29, 2026

Vaxart, Inc.
Date: April 29, 2026 · CIK: 0000072444 · Accession: 0001437749-26-013795

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-295086

Date
April 29, 2026
Author
By
Form
CORRESP
Company
Vaxart, Inc.

Letter

vxrt20260428_corresp.htm

Vaxart, Inc.

310 Utah Avenue, Suite 150

South San Francisco, CA 94080

(650) 550-3500

April 29, 2026

VIA EDGAR SUBMISSION

U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549

Re:

Vaxart, Inc. (the “ Company ” ) Registration Statement on Form S-3 (File No. 333-295086) (the “ Registration Statement ” )

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended , the Company hereby requests that the U.S. Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement to become effective on Thursday, April 30, 2026, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable, unless the Company notifies you otherwise prior to such time.

If you have any questions regarding this request, please contact our outside counsel, Faith L. Charles of Thompson Hine LLP, by telephone at (212) 908-3905 or via email at Faith.Charles@ThompsonHine.com. Please also call Faith L. Charles as soon as the Company’s Registration Statement has been declared effective. Thank you for your attention to this matter.

Sincerely,
VAXART, INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 vxrt20260428_corresp.htm

 Vaxart, Inc.

 310 Utah Avenue, Suite 150

 South San Francisco, CA 94080

 (650) 550-3500

 April 29, 2026

 VIA EDGAR SUBMISSION

 U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 Re:

 Vaxart, Inc. (the “ Company ” )
 Registration Statement on Form S-3 (File No. 333-295086) (the “ Registration Statement ” )

 Ladies and Gentlemen:

 Pursuant to Rule 461 of the Securities Act of 1933, as amended , the Company hereby requests that the U.S. Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement to become effective on Thursday, April 30, 2026, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable, unless the Company notifies you otherwise prior to such time.

 If you have any questions regarding this request, please contact our outside counsel, Faith L. Charles of Thompson Hine LLP, by telephone at (212) 908-3905 or via email at Faith.Charles@ThompsonHine.com. Please also call Faith L. Charles as soon as the Company’s Registration Statement has been declared effective. Thank you for your attention to this matter.

 Sincerely,

 VAXART, INC.

 By:

 /s/ Steven Lo

 Name:

 Steven Lo

 Title:

 President and Chief Executive Officer

 cc:

 Faith L. Charles, Thompson Hine LLP